Tumor Reduction in Primary and Metastatic Pancreatic Cancer Lesions With Nab-Paclitaxel and Gemcitabine
Pancreas - United States
doi 10.1097/mpa.0000000000000742
Full Text
Open PDFAbstract
Available in full text
Date
February 1, 2017
Authors
Publisher
Ovid Technologies (Wolters Kluwer Health)